BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ni W, Liu Q, Ren S, Li W, Yi L, Jing H, Sheng L, Wan Q, Zhong P, Fang H, Ouyang H, Xiao Z, Zhu H. The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections. Bioorganic & Medicinal Chemistry 2018;26:4145-52. [DOI: 10.1016/j.bmc.2018.07.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Li WY, Ni WW, Ye YX, Fang HL, Pan XM, He JL, Zhou TL, Yi J, Liu SS, Zhou M, Xiao ZP, Zhu HL. N-monoarylacetothioureas as potent urease inhibitors: synthesis, SAR, and biological evaluation. J Enzyme Inhib Med Chem 2020;35:404-13. [PMID: 31880473 DOI: 10.1080/14756366.2019.1706503] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
2 Wang Y. SYNTHESIS, CRYSTAL STRUCTURES, AND UREASE INHIBITORY ACTIVITY OF SCHIFF BASE COPPER AND NICKEL COMPLEXES. J Struct Chem 2021;62:1667-77. [DOI: 10.1134/s0022476621110020] [Reference Citation Analysis]
3 Feng X, Wu W, Gu Y, Zhang L, Wang S, Zhao J, Ji J, Shi D, You Z. A centipede like thiocyanate-bridged muti-nuclear copper(I/II) complex derived from 2-(((2-(dimethylamino)ethyl)imino)methyl)-5-fluorophenol with urease inhibitory activity. Journal of Coordination Chemistry. [DOI: 10.1080/00958972.2022.2062232] [Reference Citation Analysis]
4 Fiori-Duarte AT, Rodrigues RP, Kitagawa RR, Kawano DF. Insights into the Design of Inhibitors of the Urease Enzyme - A Major Target for the Treatment of Helicobacter pylori Infections. Curr Med Chem 2020;27:3967-82. [PMID: 30827224 DOI: 10.2174/0929867326666190301143549] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Ni WW, Fang HL, Ye YX, Li WY, Yuan CP, Li DD, Mao SJ, Li SE, Zhu QH, Ouyang H, Xiao ZP, Zhu HL. N-monosubstituted thiosemicarbazide as novel Ure inhibitors: synthesis, biological evaluation and molecular docking. Future Med Chem 2020;12:1633-45. [PMID: 32892642 DOI: 10.4155/fmc-2020-0048] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Mamidala R, Bhimathati SRS, Vema A. Discovery of Novel Dihydropyrimidine and hydroxamic acid hybrids as potent Helicobacter pylori Urease inhibitors. Bioorg Chem 2021;114:105010. [PMID: 34102519 DOI: 10.1016/j.bioorg.2021.105010] [Reference Citation Analysis]
7 Salehi Ashani R, Azizian H, Sadeghi Alavijeh N, Fathi Vavsari V, Mahernia S, Sheysi N, Biglar M, Amanlou M, Balalaie S. Synthesis, Biological Evaluation and Molecular Docking of Deferasirox and Substituted 1,2,4-Triazole Derivatives as Novel Potent Urease Inhibitors: Proposing Repositioning Candidate. Chem Biodivers 2020;17:e1900710. [PMID: 32187446 DOI: 10.1002/cbdv.201900710] [Reference Citation Analysis]
8 Ghobadi E, Ghanbarimasir Z, Emami S. A review on the structures and biological activities of anti-Helicobacter pylori agents. Eur J Med Chem 2021;223:113669. [PMID: 34218084 DOI: 10.1016/j.ejmech.2021.113669] [Cited by in F6Publishing: 1] [Reference Citation Analysis]